Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Metastases to adrenals
ADR ID BADD_A07414
ADR Hierarchy
05      Endocrine disorders
05.01      Adrenal gland disorders
05.01.04      Adrenal neoplasms
05.01.04.007      Metastases to adrenals
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.22      Metastases
16.22.02      Metastases to specified sites
16.22.02.012      Metastases to adrenals
Description Not Available
MedDRA Code 10027451
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adrenal metastases | Metastases to adrenals | Secondary malignant neoplasm of adrenal gland | Secondary malignant neoplasm of suprarenal gland
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00047Afatinib0.000336%
BADD_D00151Apixaban0.000043%
BADD_D00330Cabozantinib0.000168%
BADD_D00800Erlotinib0.000112%
BADD_D00858Everolimus0.000306%
BADD_D01008Gefitinib0.000168%
BADD_D01136Imatinib0.000112%
BADD_D01629Osimertinib0.000448%
BADD_D01687Pazopanib0.000280%
BADD_D01922Regorafenib0.000336%
BADD_D02029Sitagliptin0.000053%
BADD_D02058Sorafenib0.000616%
BADD_D02105Tacrolimus0.000446%
BADD_D02331Valsartan0.000053%
BADD_D02464Fingolimod0.000362%
BADD_D02586Radium ra-223 dichloride-
The 1th Page    1    Total 1 Pages